drugset / Trial / NCT00652704

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

NCT00652704

Phase 1 Completed 24 enrolled Par Pharmaceutical, Inc. Anapharm · collab
RandomizedCrossoverOpen-labelOther

Summary

To compare the rate and extent of absorption of doxycycline monohydrate capsules equivalent to 100 mg doxycycline (Par) versus Monodox (Oclassen Pharmaceuticals)

Timeline

Start
1999-07
Primary completion
1999-09
Completion
1999-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg

Indications

No indication recorded.